- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
The kinetics of SARS-CoV-2 viremia in COVID-19 patients receiving remdesivir ; volume:42 ; number:8 ; day:27 ; month:5 ; year:2023 ; pages:951-958 ; date:8.2023
European journal of clinical microbiology & infectious diseases ; 42, Heft 8 (27.5.2023), 951-958, 8.2023
- Creator
-
Krifors, Anders
Karlsson, Linda
Ekman, Martin
Lorant, Camilla
Skorup, Paul
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10096-023-04627-4
- URN
-
urn:nbn:de:101:1-2023101809275520247040
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Krifors, Anders
- Karlsson, Linda
- Ekman, Martin
- Lorant, Camilla
- Skorup, Paul
- SpringerLink (Online service)
Other Objects (12)
Utility of SARS-CoV-2 Subgenomic RNA in Kidney Transplant Recipients Receiving Remdesivir
Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
Kinetics of dengue viremia and its association with disease severity: an ambispective study
A comparative analysis of remdesivir and other repurposed antivirals against SARS‐CoV‐2
Human soluble ACE2 improves the effect of remdesivir in SARS‐CoV‐2 infection
HIV-1 persistent viremia is frequently followed by episodes of low-level viremia
Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor
Mechanisms Contributing to Control of Viremia
Safety of remdesivir in the treatment of acute SARS-CoV-2 infection in pediatric patients
Remdesivir: A Review in COVID-19
Discovery of SARS-CoV-2 antiviral synergy between remdesivir and approved drugs in human lung cells
Utility of SARS-CoV-2 Subgenomic RNA in Kidney Transplant Recipients Receiving Remdesivir
Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
Kinetics of dengue viremia and its association with disease severity: an ambispective study
A comparative analysis of remdesivir and other repurposed antivirals against SARS‐CoV‐2
Human soluble ACE2 improves the effect of remdesivir in SARS‐CoV‐2 infection
HIV-1 persistent viremia is frequently followed by episodes of low-level viremia
Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor
Mechanisms Contributing to Control of Viremia
Safety of remdesivir in the treatment of acute SARS-CoV-2 infection in pediatric patients
Remdesivir: A Review in COVID-19
Discovery of SARS-CoV-2 antiviral synergy between remdesivir and approved drugs in human lung cells
Utility of SARS-CoV-2 Subgenomic RNA in Kidney Transplant Recipients Receiving Remdesivir
Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
Kinetics of dengue viremia and its association with disease severity: an ambispective study
A comparative analysis of remdesivir and other repurposed antivirals against SARS‐CoV‐2
Human soluble ACE2 improves the effect of remdesivir in SARS‐CoV‐2 infection
HIV-1 persistent viremia is frequently followed by episodes of low-level viremia
Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor
Mechanisms Contributing to Control of Viremia
Safety of remdesivir in the treatment of acute SARS-CoV-2 infection in pediatric patients
Remdesivir: A Review in COVID-19